Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
ANKTIVA is an Interleukin-15 (IL-15) receptor agonist that helps develop and activate key cells that work to destroy cancer ...
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
The study included 30 participants between the ages 50-78, all overweight or obese (a cancer risk) yet healthy otherwise.
In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system homeostasis. When the immune system malfunctions, irregularities in cytokine ...
Abstract: Interleukin-6 is an important inflammatory cytokine with pleiotropic properties and plays an important role in inflammatory processes in disease induction and progression. This report is a ...
Six people were treated for minor injuries Thursday night after a Bronx bus smashed into a support column for an elevated subway line. Bus No. 5566 was operating on the Bx4 line and traveling east on ...
5 Department of Developmental and Regenerative biology, iORGANtech Limited Company, Jiangsu, China Background Hepatitis E virus (HEV), the leading global cause of acute viral hepatitis, lacks robust ...
Grant Darmofal scores on a 6-yard run and adds the 2-point conversion to put the Blue Devils ahead by two scores. Aaron Lague picks off Jack Luccarelli to give the Blue Devils the ball with 10:32 left ...
With the trading year coming to an end, many investors will be looking to reset for 2026. Should the S&P 500 close at about the same level it is trading at now on 12/31, we will print the third ...